Aspire Biopharma Inc. (ASBP)
NASDAQ: ASBP
· Real-Time Price · USD
0.55
0.02 (3.23%)
At close: Aug 28, 2025, 11:41 AM
Aspire Biopharma Income Statement
Financials in USD. Fiscal
year is
undefined.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -799.89K | -15.56M | -640.51K | -242.62K | -96.92K | -163.87K | -76.3K | -65.53K | -90.27K |
Interest Income | n/a | n/a | 548.68K | 76.75K | 169.91K | -246.66K | 260.67K | 255.48K | n/a |
Pretax Income | -1.98M | -15.94M | -738.5K | -242.62K | -96.92K | -163.87K | -76.3K | -65.53K | -90.27K |
Net Income | -1.98M | -15.94M | -11.97M | -243.63K | -96.92K | -163.87K | -76.78K | -65.53K | -90.27K |
Selling & General & Admin | 447K | 15.29M | 2.55M | 235.62K | 86.42K | 220.47K | 65.8K | 50.76K | 79.77K |
Research & Development | 352.89K | 263.09K | 116.36K | 7K | 10.5K | 10.5K | 10.5K | 14.78K | 10.5K |
Other Expenses | n/a | n/a | -77.41K | n/a | n/a | -67.1K | n/a | n/a | n/a |
Operating Expenses | 799.89K | 15.56M | 2.59M | 242.62K | 96.92K | 163.87K | 76.3K | 65.53K | 90.27K |
Interest Expense | 527.89K | 289.93K | 891.62K | 8.5K | 208.18K | 183.31K | 8.97K | n/a | n/a |
Selling & Marketing Expenses | 51.31K | 219.84K | -104.34K | 16.68K | 5K | 87.67K | 28.64K | n/a | 11K |
Cost & Expenses | 799.89K | 15.56M | 2.59M | 242.62K | 96.92K | 163.87K | 76.3K | 65.53K | 90.27K |
Income Tax Expense | n/a | n/a | -1.01K | 1.01K | n/a | n/a | 481.00 | n/a | n/a |
Shares Outstanding (Basic) | 49.33M | 7.77M | 7.77M | 45.94M | 45.94M | 45.94M | 45.94M | 45.94M | 45.94M |
Shares Outstanding (Diluted) | 49.33M | 7.77M | 7.77M | 45.94M | 45.94M | 45.94M | 45.94M | 45.94M | 45.94M |
EPS (Basic) | -0.04 | -2.05 | -1.15 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
EPS (Diluted) | -0.04 | -2.05 | -1.15 | -0.01 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 |
EBITDA | -1.45M | -15.65M | -8.64M | -242.62K | -96.92K | n/a | -76.3K | -65.53K | -90.27K |
EBIT | -1.45M | -15.65M | -11.08M | -242.62K | -96.92K | -163.87K | -76.3K | -65.53K | -90.27K |
Depreciation & Amortization | n/a | n/a | 2.44M | n/a | n/a | 163.87K | n/a | n/a | n/a |